Bioviz Technologies Profile
Key Indicators
- Authorised Capital ₹ 5.20 Cr
as on 07-12-2024
- Paid Up Capital ₹ 4.19 Cr
as on 07-12-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.88 Cr
as on 07-12-2024
- Revenue -86.56%
(FY 2023)
- Profit -497.72%
(FY 2023)
- Ebitda -94.83%
(FY 2023)
- Net Worth -1.96%
(FY 2023)
- Total Assets -19.89%
(FY 2023)
About Bioviz Technologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.20 Cr and a paid-up capital of Rs 4.19 Cr.
The company currently has active open charges totaling ₹3.88 Cr.
Nanne Mahammad, Hemanth Polavaram, and Mohammed Hamid serve as directors at the Company.
- CIN/LLPIN
U72300TG2007PTC053795
- Company No.
053795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2007
- Date of AGM
25 Mar 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bioviz Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemanth Polavaram  | Director | 19-Feb-2009 | Current |
| Nanne Mahammad | Director | 01-May-2007 | Current |
| Mohammed Hamid | Additional Director | 22-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Bioviz Technologies.
Bioviz Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 86.56% decrease. The company also saw a substantial fall in profitability, with a 497.72% decrease in profit. The company's net worth dipped by a decrease of 1.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioviz Technologies?
In 2023, Bioviz Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Met Therapeutics Private LimitedActive 10 years 10 monthsNanne Mahammad and Hemanth Polavaram are mutual person
- Bvz Pharma Private LimitedActive 10 years 11 months
Nanne Mahammad and Hemanth Polavaram are mutual person
- Sreemanomai Tech Solutions Private LimitedActive 3 years 3 months
Hemanth Polavaram is a mutual person
- Yaj Institute Of Management And Applied ResearchActive 14 years 8 days
Hemanth Polavaram is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 24 Feb 2010 | ₹3.88 Cr | Open |
How Many Employees Work at Bioviz Technologies?
Unlock and access historical data on people associated with Bioviz Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioviz Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioviz Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
